NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 07 04:00PM ET
3.47
Dollar change
-0.74
Percentage change
-17.46
%
IndexRUT P/E- EPS (ttm)-0.98 Insider Own47.79% Shs Outstand51.38M Perf Week-19.19%
Market Cap179.67M Forward P/E- EPS next Y-0.90 Insider Trans0.63% Shs Float26.99M Perf Month-18.04%
Enterprise Value111.36M PEG- EPS next Q-0.26 Inst Own30.92% Short Float4.25% Perf Quarter55.83%
Income-49.40M P/S2.30 EPS this Y-3.28% Inst Trans-10.39% Short Ratio6.37 Perf Half Y-4.53%
Sales78.11M P/B2.30 EPS next Y15.35% ROA-34.63% Short Interest1.15M Perf YTD-4.53%
Book/sh1.51 P/C1.65 EPS next 5Y11.93% ROE-52.87% 52W High8.45 -58.88% Perf Year-43.59%
Cash/sh2.10 P/FCF- EPS past 3/5Y8.14% -13.18% ROIC-42.02% 52W Low2.03 71.18% Perf 3Y-62.06%
Dividend Est.- EV/EBITDA- Sales past 3/5Y17.72% 27.89% Gross Margin85.66% Volatility9.37% 5.99% Perf 5Y-
Dividend TTM- EV/Sales1.43 EPS Y/Y TTM12.79% Oper. Margin-63.59% ATR (14)0.27 Perf 10Y-
Dividend Ex-Date- Quick Ratio9.99 Sales Y/Y TTM-4.16% Profit Margin-63.24% RSI (14)37.53 Recom2.43
Dividend Gr. 3/5Y- - Current Ratio10.47 EPS Q/Q16.03% SMA20-16.21% Beta2.46 Target Price3.77
Payout- Debt/Eq0.52 Sales Q/Q-9.12% SMA50-5.23% Rel Volume1.48 Prev Close4.21
Employees216 LT Debt/Eq0.51 EarningsMay 08 AMC SMA200-7.23% Avg Volume179.98K Price3.47
IPOJul 15, 2021 Option/ShortYes / Yes EPS/Sales Surpr.0.92% 6.03% Trades Volume267,059 Change-17.46%
Date Action Analyst Rating Change Price Target Change
Dec-06-24Initiated UBS Buy $5.50
Nov-04-24Downgrade Lake Street Buy → Hold $10 → $5
Aug-21-24Initiated Lake Street Buy $10
Sep-12-23Downgrade William Blair Outperform → Mkt Perform
Sep-12-23Downgrade Piper Sandler Overweight → Neutral $15 → $5.50
Sep-12-23Downgrade BofA Securities Neutral → Underperform $10 → $4.50
Aug-24-23Downgrade Morgan Stanley Overweight → Equal-Weight $12 → $8.40
Jul-10-23Downgrade Citigroup Buy → Neutral $15 → $9
Jan-06-23Upgrade Stifel Hold → Buy $10 → $15
Oct-04-22Initiated Needham Hold
May-14-25 04:05PM
May-09-25 03:41AM
May-08-25 06:30PM
05:45PM
04:05PM
11:25AM Loading…
May-07-25 11:25AM
May-05-25 05:45PM
Apr-24-25 04:05PM
Apr-23-25 04:05PM
Apr-22-25 04:05PM
Apr-21-25 04:05PM
Mar-25-25 04:05PM
Mar-06-25 12:09PM
02:11AM
Mar-05-25 06:00PM
05:20PM Loading…
05:20PM
04:05PM
Mar-04-25 07:25AM
Feb-26-25 10:00AM
Feb-24-25 04:05PM
Feb-19-25 04:05PM
Feb-13-25 04:05PM
Jan-14-25 08:00AM
Jan-07-25 04:05PM
Dec-19-24 04:05PM
Dec-07-24 05:31AM
Nov-19-24 04:05PM
Nov-18-24 10:00AM
Nov-12-24 06:50AM
Nov-08-24 06:02AM
07:05PM Loading…
Nov-07-24 07:05PM
04:05PM
04:04PM
Nov-06-24 07:43AM
Oct-17-24 04:05PM
Oct-14-24 04:05PM
Aug-21-24 09:36AM
Aug-20-24 04:05PM
Aug-02-24 11:30AM
Aug-01-24 06:45PM
04:05PM
Jul-18-24 04:05PM
Jun-10-24 04:05PM
May-28-24 04:05PM
08:30AM
May-07-24 04:05PM
May-06-24 10:02AM
May-03-24 01:37PM
01:04PM
May-02-24 09:55PM
06:20PM
04:05PM
Apr-30-24 11:02AM
Apr-29-24 03:55PM
01:59PM
11:21AM
10:51AM
08:05AM
Apr-18-24 04:05PM
Apr-10-24 04:05PM
Apr-02-24 04:05PM
Mar-26-24 04:05PM
Mar-08-24 02:53PM
09:16AM
Mar-07-24 10:35PM
09:53PM
05:50PM
04:05PM
Feb-22-24 04:05PM
Feb-21-24 10:25AM
Feb-14-24 04:05PM
Jan-23-24 04:05PM
Jan-14-24 05:25PM
Jan-08-24 04:05PM
Dec-28-23 09:15AM
Dec-18-23 04:05PM
Dec-08-23 08:05AM
Nov-13-23 03:40PM
Nov-12-23 09:40AM
Nov-07-23 04:05PM
Oct-26-23 05:30PM
Oct-24-23 04:05PM
Oct-19-23 04:05PM
Oct-12-23 04:05PM
Oct-03-23 08:30AM
Sep-12-23 09:53AM
02:55AM
Sep-11-23 04:06PM
04:05PM
Aug-30-23 04:05PM
Aug-03-23 06:35PM
04:05PM
Jul-24-23 09:55AM
Jul-20-23 04:05PM
08:30AM
Jul-17-23 12:00PM
Jun-21-23 08:30AM
Jun-09-23 04:05PM
May-23-23 08:30AM
May-09-23 09:55AM
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HAYDEN JEREMY B.Chief Legal OfficerJul 03 '25Sale4.179,16038,234266,321Jul 07 09:32 PM
Bauerlein AlisonChief Financial OfficerJul 02 '25Sale4.1019,26078,927617,468Jul 07 09:27 PM
Badawi PaulPresident and CEOJul 01 '25Sale4.1523,63798,1415,986,943Jul 07 09:27 PM
Badawi DavidChief Technology OfficerJul 03 '25Sale4.175,67923,7041,831,025Jul 07 09:25 PM
Link MatthewChief Commercial OfficerJul 02 '25Sale4.104,88920,035832,293Jul 07 09:24 PM
Badawi DavidOfficerJul 03 '25Proposed Sale4.175,67923,705Jul 03 03:13 PM
HAYDEN JEREMY B.OfficerJul 03 '25Proposed Sale4.179,16038,236Jul 03 03:05 PM
Link MatthewOfficerJul 02 '25Proposed Sale4.104,88920,037Jul 02 04:45 PM
Bauerlein AlisonOfficerJul 02 '25Proposed Sale4.1019,26078,933Jul 02 04:37 PM
Badawi PaulOfficerJul 01 '25Proposed Sale4.1523,63798,134Jul 01 04:27 PM
Encrantz StaffanDirectorJun 05 '25Buy4.2440,951173,7961,319,112Jun 06 09:10 PM
Encrantz StaffanDirectorJun 06 '25Buy4.2227,900117,7381,377,964Jun 06 09:10 PM
Encrantz StaffanDirectorJun 04 '25Buy4.1721,67490,4241,278,161Jun 06 09:10 PM
Encrantz StaffanDirectorMay 30 '25Buy3.6742,753156,9041,200,458Jun 03 09:57 PM
Encrantz StaffanDirectorJun 02 '25Buy3.8830,799119,4391,231,257Jun 03 09:57 PM
Encrantz StaffanDirectorJun 03 '25Buy3.9725,230100,0871,256,487Jun 03 09:57 PM
Encrantz StaffanDirectorMay 29 '25Buy3.5960,128215,7391,157,705May 29 09:31 PM
Encrantz StaffanDirectorMay 27 '25Buy3.4441,346142,0651,070,862May 29 09:31 PM
Encrantz StaffanDirectorMay 28 '25Buy3.5226,71593,9301,097,577May 29 09:31 PM
Bauerlein AlisonChief Financial OfficerMay 19 '25Sale3.4813,06645,430636,728May 21 08:38 PM
Bauerlein AlisonOfficerMay 19 '25Proposed Sale3.4813,06645,430May 19 03:52 PM
HAYDEN JEREMY B.Chief Legal OfficerApr 02 '25Sale2.319,39521,693275,481Apr 03 09:57 PM
Badawi PaulPresident and CEOApr 01 '25Sale2.3024,17455,6736,010,580Apr 03 09:56 PM
Link MatthewChief Commercial OfficerApr 02 '25Sale2.315,04211,642830,551Apr 03 09:56 PM
Badawi DavidChief Technology OfficerApr 01 '25Sale2.305,98013,7721,836,704Apr 03 09:55 PM
Bauerlein AlisonChief Financial OfficerApr 02 '25Sale2.3119,39744,788649,794Apr 03 09:54 PM
Link MatthewOfficerApr 02 '25Proposed Sale2.315,04211,642Apr 02 04:34 PM
HAYDEN JEREMY B.OfficerApr 02 '25Proposed Sale2.319,39521,694Apr 02 04:27 PM
Bauerlein AlisonOfficerApr 02 '25Proposed Sale2.3119,39744,790Apr 02 04:13 PM
Badawi PaulOfficerApr 01 '25Proposed Sale2.3024,17455,682Apr 01 04:57 PM
Badawi DavidOfficerApr 01 '25Proposed Sale2.305,98013,774Apr 01 04:26 PM
Raheja Manohar K.EVP, Research & DevelopmentMar 12 '25Buy2.7310,00027,250145,000Mar 13 09:51 PM
Raheja Manohar K.EVP, Research & DevelopmentMar 13 '25Buy2.6010,00026,000155,000Mar 13 09:51 PM
Badawi DavidChief Technology OfficerJan 17 '25Sale2.785,42315,0811,744,118Jan 21 09:58 PM
Badawi PaulPresident and CEOJan 16 '25Sale2.9224,81972,5715,676,331Jan 21 09:58 PM
HAYDEN JEREMY B.Chief Legal OfficerJan 17 '25Sale2.786,92219,250145,091Jan 21 09:58 PM
HAYDEN JEREMY B.OfficerJan 17 '25Proposed Sale2.786,92219,249Jan 17 03:17 PM
Badawi DavidOfficerJan 17 '25Proposed Sale2.785,42315,081Jan 17 03:06 PM
Badawi PaulOfficerJan 16 '25Proposed Sale2.9224,81972,571Jan 16 04:14 PM
HAYDEN JEREMY B.Chief Legal OfficerJan 08 '25Sale3.261,8105,899152,013Jan 10 06:10 AM
Badawi DavidChief Technology OfficerJan 08 '25Sale3.263,82912,4791,749,541Jan 10 06:09 AM
Badawi DavidOfficerJan 08 '25Proposed Sale3.263,82912,479Jan 08 03:12 PM
HAYDEN JEREMY B.OfficerJan 08 '25Proposed Sale3.261,8105,899Jan 08 03:09 PM
Badawi DavidChief Technology OfficerJan 03 '25Sale3.523,11110,9571,753,370Jan 06 09:48 PM
HAYDEN JEREMY B.Chief Legal OfficerJan 03 '25Sale3.524,86417,131153,823Jan 06 09:47 PM
Bauerlein AlisonChief Financial OfficerJan 03 '25Sale3.5210,10235,579382,453Jan 06 09:47 PM
Badawi PaulPresident and CEOJan 02 '25Sale3.6012,23644,0135,713,197Jan 06 09:46 PM
HAYDEN JEREMY B.OfficerJan 03 '25Proposed Sale3.524,86417,132Jan 03 05:20 PM
Bauerlein AlisonOfficerJan 03 '25Proposed Sale3.5210,10235,582Jan 03 04:55 PM
Badawi DavidOfficerJan 03 '25Proposed Sale3.523,11110,958Jan 03 04:38 PM
Park Sam BoongFormer OfficerJan 02 '25Proposed Sale3.603,32311,953Jan 02 03:45 PM
Badawi PaulOfficerJan 02 '25Proposed Sale3.6012,23644,014Jan 02 03:43 PM
Raheja Manohar K.EVP, Research & DevelopmentDec 06 '24Buy3.855,00019,250111,000Dec 09 06:16 PM
Raheja Manohar K.EVP, Research & DevelopmentDec 03 '24Buy3.893,37613,133106,000Dec 05 08:18 PM
Raheja Manohar K.EVP, Research & DevelopmentNov 29 '24Buy3.994,62418,441102,624Dec 03 06:40 PM
Raheja Manohar K.EVP, Research & DevelopmentNov 19 '24Buy3.702,0007,40098,000Nov 21 09:18 PM
Encrantz StaffanDirectorNov 21 '24Buy3.73551,8022,058,2214,573,920Nov 21 09:12 PM
Encrantz StaffanDirectorNov 21 '24Sale3.73551,8022,058,221632,456Nov 21 09:12 PM
Link MatthewChief Commercial OfficerOct 18 '24Sale5.9820,487122,451685,381Oct 21 09:46 PM
Link MatthewChief Commercial OfficerOct 21 '24Sale5.6121,831122,450663,550Oct 21 09:46 PM
Link MatthewOfficerOct 21 '24Proposed Sale5.6121,831122,441Oct 21 04:13 PM
Link MatthewChief Commercial OfficerOct 17 '24Sale5.8420,970122,444705,868Oct 18 07:43 PM
Link MatthewChief Commercial OfficerOct 16 '24Sale5.9120,734122,434726,838Oct 18 07:43 PM
Link MatthewOfficerOct 18 '24Proposed Sale5.9820,487122,441Oct 18 03:44 PM
Link MatthewOfficerOct 17 '24Proposed Sale5.8420,970122,438Oct 17 04:27 PM
Link MatthewOfficerOct 16 '24Proposed Sale5.9120,734122,440Oct 16 04:01 PM
Badawi PaulPresident and CEOOct 02 '24Sale5.9912,72776,1845,725,433Oct 03 09:57 PM
HAYDEN JEREMY B.Chief Legal OfficerOct 01 '24Sale6.084,87829,658158,687Oct 03 09:57 PM
Badawi DavidChief Technology OfficerOct 02 '24Sale5.993,16718,9581,756,481Oct 03 09:53 PM
Bauerlein AlisonChief Financial OfficerOct 01 '24Sale6.0810,13061,590392,555Oct 03 09:53 PM
Park Sam BoongChief Operating OfficerOct 01 '24Sale6.083,40320,690254,826Oct 03 09:52 PM
Badawi PaulOfficerOct 02 '24Proposed Sale5.9912,72776,183Oct 02 04:51 PM
Badawi DavidOfficerOct 02 '24Proposed Sale5.993,16718,957Oct 02 04:08 PM
Bauerlein AlisonOfficerOct 01 '24Proposed Sale6.0810,13061,586Oct 01 03:52 PM
Park Sam BoongOfficerOct 01 '24Proposed Sale6.083,40320,689Oct 01 03:40 PM
HAYDEN JEREMY B.OfficerOct 01 '24Proposed Sale6.084,87829,656Oct 01 03:37 PM